london euretina
retina race

Outcome of primary rhegmatogenous retinal detachment surgery in a tertiary referral centre in Northern Ireland: a regional study

Session Details

Session Title: Vitreoretinal Surgery I

Session Date/Time: Thursday 17/09/2015 | 08:30-10:30

Paper Time: 09:18

Venue: Apollon.

First Author: : M.Mikhail UNITED KINGDOM

Co Author(s): :    G. Mangioris   W. Chan           

Abstract Details

PURPOSE:To report the primary and final success rate, functional outcome and complication rate of patients with primary rhegmatogenous retinal detachment (RRD) who underwent retinal detachment surgery in a tertiary referral centre in Northern Ireland.

Setting:

Vitreo-retinal service, Royal Victoria Hospital, Belfast

Methods:

This is a retrospective case series of all patients who underwent primary RRD repair between 1st of January 2013 and 31st of December 2013. Case charts were reviewed. Patients’ demographics, overall primary and final success rate, functional outcome, complications and failure rates were identified and recorded.

Results:

A total of two hundreds and twelve cases of primary RRD were included. Mean age at time of surgery was 56.6 years (range 9-90 years). Of 212 eyes; 175(82.5%) had pars plana vitrectomy (PPV), 27 (12.5%) had scleral buckle (SB) repair, and 10 (5%) had pneumatic retinopexy (PR). Overall primary and final success rate were 86% and 95.6% respectively. Subgroup analysis according to lens status and foveal attachment was also performed. There was a significant difference in the primary success rate between the phakic and pseudophakic group. Overall mean visual acuity improved from 1.1 LogMar to 0.4 LogMar postoperatively. Poor prognostic factors led to failure were proliferative vitreoretinophathy (PVR) at presentation, inferior breaks, number of quadrants detached, and pseudophakia.

Conclusions:

This study demonstrates comparable success rate to other centres where there is specialist-led service. The nature of retinal detachment dictates significant failure rate despite high volume of cases; therefore in addition to maintaining excellent surgical techniques, new therapies are needed to reduce failure rate.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy